Profile | GDS2987 / GI_28872811-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 16.2 | 49 |
GSM215244 | HMVEC_vehicle_rep2 | 34 | 61 |
GSM215253 | HMVEC_vehicle_rep3 | 43.5 | 69 |
GSM215254 | HMVEC_atorvastatin_rep1 | 35.4 | 63 |
GSM215282 | HMVEC_atorvastatin_rep3 | 21 | 44 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 10.3 | 20 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 13 | 22 |
GSM215294 | HMVEC_SLx2119_rep1 | 50.2 | 71 |
GSM215295 | HMVEC_SLx2119_rep2 | 13.5 | 27 |
GSM215296 | HMVEC_SLx2119_rep3 | 34.1 | 49 |
GSM215297 | PASMC_vehicle_rep1 | 15.7 | 24 |
GSM215298 | PASMC_vehicle_rep2 | 70 | 68 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 27 | 43 |
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 27.1 | 42 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 43 | 60 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 32.4 | 49 |
GSM215327 | PASMC_SLx2119_rep1 | 33.3 | 50 |
GSM215328 | PASMC_SLx2119_rep2 | 25.5 | 42 |
GSM215329 | PASMC_SLx2119_rep3 | 30.3 | 50 |
GSM215330 | Fibroblasts_vehicle_rep1 | 42.6 | 64 |
GSM215331 | Fibroblasts_vehicle_rep2 | 122 | 77 |
GSM215332 | Fibroblasts_vehicle_rep3 | 99 | 75 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 80.8 | 74 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 126.4 | 77 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 112.7 | 76 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 108.7 | 76 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 89.9 | 74 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 118 | 76 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 79.7 | 73 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 79.9 | 73 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 77.6 | 73 |